Symbiosis Appoints Jay Chima as VP, Business Development

Symbiosis Pharmaceutical Services, a specialist aseptic fill-finish Contract Development and Manufacturing Organization (CDMO), has appointed Jay Chima as Vice President, Business Development, bringing more than 16 years of commercial experience to support the company’s next phase of growth and strengthen partnerships with pharmaceutical and biotechnology innovators.

Based in London, Chima will work across Symbiosis’ commercial organization to strengthen relationships with existing customers, establish new strategic partnerships and provide market insight that supports the company’s continued growth and future investment plans.

Joanne Anderson, Chief Commercial Officer at Symbiosis, said: “Jay brings a proven track record of building strategic partnerships, identifying growth opportunities and delivering commercial success across multiple pharmaceutical sectors. His experience across both emerging biotechnology companies and global pharmaceutical organizations gives him a valuable understanding of the challenges customers face at different stages of development.”

“We’re delighted to welcome him to the team and look forward to the contribution he’ll make in supporting our long-term growth ambitions,” she added.

Experience

Chima joins Symbiosis from Recipharm, where he served as Business Development Director and prior to that he held senior commercial positions at MedPharm and Advanz Pharma, building extensive experience supporting organizations ranging from emerging biotechnology companies to global pharmaceutical groups.

Commenting on his appointment, Chima said: “What attracted me to Symbiosis was its unique combination of technical capability, proven delivery, agility and customer focus. It occupies what I believe is the sweet spot within the CDMO sector; large enough to support complex programs and commercial ambitions, yet agile enough to respond quickly to customer needs and provide the attention many drug developers are seeking.”